This inventor holds 108 USPTO granted patents and 17 published patent applications, plus 4 CIPO patents and 7 EPO patents, primarily in Nitric Oxide Synthase Inhibitors (CPC class C07D401-14). Top assignees: Northwestern University, Warner-Lambert Company, Cambria Pharmaceuticals, Inc.. Active years: 1985-2026.
Inventors with similar research interests:
Location History:
- Chicago, IL (US) (1985 - 1986)
- Morton Grove, MI (US) (1998)
- Morton Grove, IL (US) (1996 - 2003)
- Northbrook, IL (2012)
- Northbrook, IL (US) (2001 - 2018)
- Evanston, IL (US) (2020 - 2022)
- Winnetka, IL (US) (2014 - 2024)
Company Filing History:
96 out of 2,209 
8 out of 2,538 
4 out of 4 
Years Active: 1985-2026
Areas of Expertise:
Title: The Innovative Journey of Richard B. Silverman
Introduction: Richard B. Silverman, a distinguished inventor hailing from Winnetka, IL (US), has made significant contributions to the field of innovation with his groundbreaking work.
Latest Patents: Richard B. Silverman holds several patents in the field of pharmaceuticals and organic chemistry, with his most recent patent focusing on novel drug compounds for the treatment of neurological disorders.
Career Highlights: Throughout his illustrious career, Richard B. Silverman has been a trailblazer in the development of new drugs and treatments. His work has led to the creation of life-saving medications and therapies that have positively impacted countless lives around the world.
Collaborations: Richard B. Silverman has collaborated with leading researchers, scientists, and pharmaceutical companies to further his research and bring his inventions to market. His collaborative efforts have been instrumental in advancing the field of pharmaceuticals.
Conclusion: In conclusion, Richard B. Silverman's dedication to innovation and his pioneering spirit have solidified his legacy as a visionary inventor in the field of pharmaceuticals. His contributions continue to shape the landscape of modern medicine, making the world a better place for all.